Tagapan, Letty B.
HRN: 24 43 84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/16/2024
01/22/2024
IV
600mg
Q8
Non Healing Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes